🇺🇸 Estracomb TTS in United States
7 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 7
Most-reported reactions
- Deafness — 1 report (14.29%)
- Deafness Unilateral — 1 report (14.29%)
- Eye Operation — 1 report (14.29%)
- Glucose Tolerance Impaired — 1 report (14.29%)
- Hypertension — 1 report (14.29%)
- Lipids Increased — 1 report (14.29%)
- Weight Increased — 1 report (14.29%)
Other Endocrinology / Women's Health approved in United States
Frequently asked questions
Is Estracomb TTS approved in United States?
Estracomb TTS does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Estracomb TTS in United States?
Anna Posadzy-Małaczyńska is the originator. The local marketing authorisation holder may differ — check the official source linked above.